IMCC
Im Cannabis Corp
NASDAQ: IMCC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.28
+10.70% today
Updated 2026-04-30
Market cap
$1.72M
P/E ratio
—
P/S ratio
0.03x
EPS (TTM)
$-1.95
Dividend yield
—
52W range
$0 – $7
Volume
0.6M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+2.5
Quality
F2.0
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-8.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$8.22
+2800.49%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $4.22M — positive
+ Revenue growth 17.60% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -8.91 — distress zone
- Thin margins at -20.70%
- Debt/equity 4.43x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $54.34M | $48.80M | $54.03M | $54.73M | $54.73M |
| Net income | $-188.89M | $-9.50M | $-10.59M | $-11.32M | $-7.63M |
| EPS | — | — | — | — | $-1.95 |
| Free cash flow | $-14.20M | $-8.66M | $-1.23M | $4.70M | $4.22M |
| Profit margin | -347.64% | -19.46% | -19.59% | -20.68% | -20.70% |
Peer comparison
Smart narrative
Im Cannabis Corp trades at $0.28. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -8.91, it sits in the distress. TTM revenue stands at $54.73M. with profit margins at -20.70%.
Frequently asked questions
What is Im Cannabis Corp's stock price?
Im Cannabis Corp (IMCC) trades at $0.28.
Is Im Cannabis Corp overvalued?
Smart Value Score 37/100 (Grade D, Sell).
What is the price target of Im Cannabis Corp (IMCC)?
The analyst target price is $8.22, representing +2800.5% upside from the current price of $0.28.
What is Im Cannabis Corp's revenue?
TTM revenue is $54.73M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-8.91 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.03x
ROE-119.80%
Beta2.27
50D MA$0.60
200D MA$1.55
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—